Four students participate in Winship's newest summer research internship

Supported by new funding from the American Cancer Society, Winship’s Diversity in Cancer Research Internship is a 10-week summer program launched this year for undergraduate students from racial and ethnic backgrounds underrepresented in the scientific community. Led by Lawrence Boise, PhD, the internship offers hands-on research experience in Winship labs, career development, peer networking opportunities, and small group learning sessions.

About the Internship

Video: Emory and Atlanta Braves team up to promote sun safety

Emory Healthcare and the Atlanta Braves are teaming up to promote sun safety. Watch Ragini Kudchadkar, MD, and Braves legend Paul Byrd as they practice “the five S’s” of sun safety.

Watch Video

Video: Winship Webinar on supportive and palliative oncology

Winship specialists Kimberly Curseen, MD, and Ali Zarrabi, MD, discussed the role of supportive and palliative oncology during a live Winship Webinar on June 21.

Watch Webinar

Lorenz receives Emory HOPE Award

Radiation oncology resident Joshua Lorenz, MD, has received a 2021 House Staff Organization Professionalism Excellence (HOPE) Award from Emory University School of Medicine. The award recognizes residents and fellows who demonstrate exceptional professionalism in working with patients and colleagues.

Call for nominations: Elkin Lecture speakers

The Winship Elkin Lecture Series, held Fridays at 12:15 p.m., seeks speakers who reflect the institution's values of diversity and inclusion and who represent a broad spectrum of cancer interests, including basic, translational, clinical, data science, and population-based research.

View Nomination Form

Below are four selected Winship publications out of 72 published over the past week:

Jagannath S, Lin Y, Goldschmidt H, Reece D, Nooka A, Senin A, Rodriguez-Otero P, Powles R, Matsue K, Shah N, Anderson LD, Streetly M, Wilson K, Le HV, Swern AS, Agarwal A, Siegel DS. KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma. Blood Cancer Journal. 2021; 11(6):116. PubMed PMID: 34145225.

View in PubMed

Herting CJ, Farren MR, Tong Y, Liu Z, O'Neil B, Bekaii-Saab T, Noonan A, McQuinn C, Mace TA, Shaib W, Wu C, El-Rayes BF, Shahda S, Lesinski GB. A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology, Immunotherapy. 2021; PubMed PMID: 34160684.

View in PubMed

Abernethy ER, Campbell GP, Hianik RS, Thomson MC, Blee SM, Sibold HC, Dixon MD, Switchenko JM, Pentz RD. Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting. Cancer. 2021; PubMed PMID: 34161615.

View in PubMed

Sterrett MC, Enyenihi L, Leung SW, Hess L, Strassler SE, Farchi D, Lee RS, Withers ES, Kremsky I, Baker RE, Basrai MA, van Hoof A, Fasken MB, Corbett AH. A Budding Yeast Model for Human Disease Mutations in the EXOSC2 Cap Subunit of the RNA Exosome. RNA (New York, N.Y.). 2021; PubMed PMID: 34162742.

View in PubMed